7 completed. 7 Phase 2.
By phase and status
Follow PH-797804: new trials by email Literature Review of PH-797804 trials Research Report on PH-797804
Trials (filtered) newest first · largest first
All 7 trials
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix .
Trial Phase Status Sponsor Enrollment Start Updated
Study To Evaluate The Efficacy And Safety Of PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium Bromide PH-797804, Placebo - Pulmonary Disease, Chronic Obstructive Phase 2 Completed 730 2012-04-01 2014-10-27 Study To Evaluate The Efficacy And Safety Of PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) Taking Salmeterol Xinafoate/Fluticasone Propionate Combination PH-797804, Placebo - Pulmonary Disease, Chronic Obstructive Phase 2 Completed 377 2011-05-01 2013-07-11 Clinical Trial to Examine the Pain Relief of PH-797804 Alone Or With Naproxen in Subjects With Osteoarthritis of the Knee PH-797804, Placebo, Naproxen - Osteoarthritis Phase 2 Completed 172 2010-05-01 2014-08-22 PH-797804 Versus Placebo For The Treatment Of Neuropathic Pain Associated With Post-Herpetic Neuralgia PH-797804, Placebo - Neuralgia, Postherpetic Phase 2 Completed 80 2008-04-01 2011-05-16 A Study To Evaluate The Safety And Pharmacokinetic Profile Of A P38 Inhibitor (PH-797804) In Subjects With Rheumatoid Arthritis Who Are Also Taking Methotrexate Placebo, PH-797804 - Arthritis, Rheumatoid Phase 2 Completed 27 2008-03-01 2018-11-08 A Phase II, Study To Evaluate The Efficacy And Safety Of PH-797804 In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD). PH-797804, Placebo - Chronic Obstructive Pulmonary Disease Phase 2 Completed 230 2008-02-01 2018-10-16 An Oral p38 Inhibitor Investigating Safety, Efficacy, And PK In Subjects With Active Rheumatoid Arthritis placebo, PH-797804 - Arthritis, Rheumatoid Phase 2 Completed 305 2006-12-15 2021-08-20
Conditions studied Pulmonary Disease, Chronic Obstructive (3) · Arthritis, Rheumatoid (2) · Arthritis (1) · Neuralgia, Postherpetic (1) · Osteoarthritis (1) · Osteoarthritis, Knee (1)
Sponsors Pfizer (7)
Countries Chile (4) · Czechia (4) · South Africa (4) · United States (4) · Argentina (3) · Australia (3) · Canada (3) · Hungary (3) · Poland (3) · Russia (3) · Spain (3) · Sweden (3) · United Kingdom (3) · Bulgaria (2) · India (2)
Results publications PMID 23539534